Full View

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano… - Proceedings of the …, 2022 - National Acad Sciences
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …
被引用次数：28 相关文章
[HTML] nih.gov

[HTML][HTML] Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano, H Liu… - Proceedings of the …, 2022 - ncbi.nlm.nih.gov
Results J08 Cross-Neutralizes All Current SARS-CoV-2 VoCs. To evaluate neutralization
breadth, J08 was tested for binding, ACE2 blocking, and neutralization against the SARS …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano, H Liu… - … OF THE NATIONAL …, 2022 - air.unimi.it
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

J Torres, G Ozorowski, E Andreano… - Proceedings of the …, 2022 - pasteur.hal.science
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …
[PDF] archive.org

[PDF][PDF] Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano, H Liu, J Copps… - scholar.archive.org
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano, H Liu, J Copps… - bioRxiv, 2021 - biorxiv.org
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano… - Proceedings of the …, 2022 - ui.adsabs.harvard.edu
Clinical candidate monoclonal antibody J08 binds the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) S-protein independent of known escape mutations and is able …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

JL Torres, G Ozorowski, E Andreano… - Proceedings of the …, 2022 - pubmed.ncbi.nlm.nih.gov
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

J Torres, G Ozorowski, E Andreano, H Liu… - Proceedings of the …, 2022 - hal.em-lyon.com
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

J Torres, G Ozorowski, E Andreano, H Liu… - Proceedings of the …, 2022 - hal.science
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for
highly potent monoclonal antibodies (mAbs) that are resistant against severe acute …